#News for #Investors and #Media: At the upcoming 2025 ASCO Annual Meeting, we’re proud to present 23 abstracts that reflect our one collective mission: to improve outcomes for cancer patients worldwide. Our presentations span long-term results in hematologic cancers, first-time data in breast cancer, and new evidence across our solid tumor franchise, highlighting the breadth and potential of our global oncology portfolio. We look forward to connecting, sharing insights, and driving impactful conversations with experts worldwide. Explore the data and our presence at #ASCO25: https://ow.ly/pTC750VWX0O
BeOne Medicines
Biotechnology Research
Cambridge, Massachusetts 202,623 followers
Cancer has no borders. Neither do we.
About us
BeOne Medicines USA, Inc. is the U.S. affiliate of BeiGene, Ltd., a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting the development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents. To learn more about BeOne, please visit www.beigene.com and follow us on LinkedIn, YouTube, Instagram, X, and Facebook.
- Website
-
www.beigene.com
External link for BeOne Medicines
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- oncology, hematology, cancer treatment, solid tumor, and targeted therapy
Locations
Employees at BeOne Medicines
Updates
-
May is #MentalHealthAwarenessMonth, a timely reminder that a cancer diagnosis affects more than just the body—it impacts the mind as well. Research shows over one-third of cancer patients experience loneliness after diagnosis, and two-thirds don’t receive a mental health referral. At BeOne, guided by our core value of #PatientsFirst, we’re committed to working with the cancer community to address the emotional challenges that often accompany cancer. Because treating the whole patient means caring for both physical and emotional well-being – and studies show that doing so can lead to better health outcomes. Check out our latest #TalkAboutIt blog, where we offer practical tips and insights for coping with the emotional challenges of a cancer diagnosis: https://ow.ly/tSBO50VVUQy #MentalHealth #MHAM2025
-
-
This #InternationalClinicalTrialsDay, and every day, we recognize the vital role clinical trials play in advancing science and improving patient care across the globe. Despite progress, barriers to trial participation still exist — and we're committed to breaking them down by fostering greater diversity and inclusion in clinical research. With an extensive internal development team, we’re able to run clinical trials in-house to lower costs, accelerate timelines, and create a broader clinical footprint that gets our medicines to more people around the world. Hear more from Melika Davis, SVP & Global Head of Clinical Operations, on our #CancerHasNoBorders podcast, where she shares insights into the importance of clinical trials and how we lead them from strategy through execution worldwide: https://ow.ly/y3Q050VVaTB #ClinicalTrials #ClinicalResearch #PatientCare
-
We’re proud to support the Lymphoma Research Foundation’s upcoming webinar on chronic lymphocytic leukemia/small lymphocytic lymphoma — an interactive program focused on diagnosis, treatment updates, and expert Q&A. Programs like this provide patients and caregivers with trusted information and direct access to leading experts, which are a vital part of advancing care and support. Learn more and register for next week's webinar here: https://ow.ly/qQPj50VV4xq #CLL
-
-
We’re honored to be ranked among the top 10 companies for Invention in IDEA Pharma’s 2025 Pharmaceutical Invention Index—an annual benchmark that evaluates the novelty and breadth of pharmaceutical pipelines across the industry. This recognition underscores the strength of our differentiated R&D model. By driving discovery in-house and running our own clinical trials, we’ve built a prolific pipeline targeting the world’s most deadly cancers. This approach enables us to rapidly identify, develop, and advance high-potential molecules—aiming to deliver first-in-class and best-in-class therapies that truly make a difference. Thank you, IDEA Pharma | From R&D to RxD, for recognizing our commitment to pioneering science and pushing the boundaries of innovation in R&D. Learn more: https://ow.ly/LMvx50VTAEa
-
-
#News for #Investors and #Media: Our #oncology therapy has recently been reimbursed by the Health Ministry of Luxembourg. This milestone further underscores our commitment to providing new treatment options to eligible cancer patients across Europe and around the world.
-
-
May is Mental Health Awareness Month – let’s #TalkAboutIt. We believe mental health support can improve quality of life and health outcomes for people impacted by cancer. Our Talk About It: Cancer and Mental Health program provides innovative support strategies and elevates mental health conversations to support people throughout their entire cancer journey. The first step is to talk about it. Learn more about the program or download resources here: https://ow.ly/LUNa50VRr4r #MentalHealth #CancerHasNoBorders #MentalHealthAwarenessMonth #MHAM2025
-
#News for #Investors and #Media: With 31 accepted abstracts at #EHA25, including four oral presentations, we are advancing innovation in B-cell malignancies with data across our hematology portfolio and pipeline. Learn more about our presence at the meeting: https://lnkd.in/ew9awJUs
-
This past weekend, BeOne leaders and colleagues across the U.S. laced up their shoes for CLL Society’s #CelebratingLongLives virtual 5k! This annual race unites the community in support of people impacted by CLL/SLL, while raising funds to propel CLL Society’s mission forward. We were proud to once again serve as a Silver Sponsor of the race that raised more than $55,000. Congratulations to CLL Society for another successful event and thank you to all who participated to support patients! #TeamBeOne #CLL5K25 #CancerHasNoBorders #PatientsFirst #CLL
-